Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in α2A-adrenoceptor knockout mice

European Journal of Pharmacology

Volumn 578, Issue 2-3, 2008, Pages 359-364

  Savontaus, Eriika ^a   Fagerholm, Veronica ^b   Rahkonen, Olli ^a   Scheinin, Mika ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU PET CENTRE   (Finland)

Author keywords

2A adrenoceptor; (Mouse); Diabetes; Glucagon; Glucose; Insulin

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTERONE; GLUCAGON; GLUCOSE; INSULIN; MUSCARINIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SEX DIFFERENCE; WILD TYPE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ATROPINE; BLOOD GLUCOSE; CORTICOSTERONE; FASTING; FEMALE; GLUCAGON; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCARINIC ANTAGONISTS; PROPRANOLOL; RECEPTORS, ADRENERGIC, ALPHA-2; TIME FACTORS;

EID: 37449004981     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.09.015     Document Type: Article

References (41)

1. Ahrén B., Simonsson E., Scheurink A.J., Mulder H., Myrsen U., and Sundler F. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 46 (1997) 97-106
2. Ahrén B., Sauerberg P., and Thomsen C. Increased insulin secretion and normalization of glucose tolerance by cholinergic agonism in high fat-fed mice. Am. J. Physiol. 277 (1999) E93-E102
3. Altman J.D., Trendelenburg A.U., MacMillan L., Bernstein D., Limbird L., Starke K., Kobilka B.K., and Hein L. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol. Pharmacol. 56 (1999) 154-161
4. Angel I., Niddam R., and Langer S.Z. Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia. J. Pharmacol. Exp. Ther. 254 (1990) 877-882
5. Bailey C.J., and Flatt P.R. Hormonal control of glucose homeostasis during development and ageing in mice. Metabolism 31 (1982) 238-246
6. Boden G., Master R.W., Sattler M.A., Martin J.S., Tansy M.F., and Owen O.E. Adrenergic control of somatostatin release. Endocrinology 111 (1982) 1166-1172
7. Brede M., Nagy G., Philipp M., Sørensen J.B., Lohse M.J., and Hein L. Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes. Mol. Endocrinol. 17 (2003) 1640-1646
8. Burcelin R., Uldry M., Foretz M., Perrin C., Dacosta A., Nenniger-Tosato M., Seydoux J., Cotecchia S., and Thorens B. Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype. J. Biol. Chem. 279 (2004) 1108-1115
9. Chu C.A., Sindelar D.K., Igawa K., Sherck S., Neal D.W., Emshwiller M., and Cherrington A.D. The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E463-E473
10. Deibert D.C., and DeFronzo R.A. Epinephrine-induced insulin resistance in man. J. Clin. Invest. 65 (1980) 717-721
11. Devedjian J.C., Pujol A., Cayla C., George M., Casellas A., Paris H., and Bosch F. Transgenic mice overexpressing alpha(2A)-adrenoceptors in pancreatic beta-cells show altered regulation of glucose homeostasis. Diabetologia 43 (2000) 899-906
12. Duttaroy A., Zimliki C.L., Gautam D., Cui Y., Mears D., and Wess J. Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice. Diabetes 53 (2004) 1714-1720
13. Erraji-Benchekroun L., Couton D., Postic C., Borde I., Gaston J., Guillet J.G., and Andre C. Overexpression of beta2-adrenergic receptors in mouse liver alters the expression of gluconeogenic and glycolytic enzymes. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E715-E722
14. Fagerholm V., Grönroos T., Marjamäki P., Viljanen T., Scheinin M., and Haaparanta M. Altered glucose homeostasis in alpha2A-adrenoceptor knockout mice. Eur. J. Pharmacol. 505 (2004) 243-252
15. Filipponi P., Gregorio F., Ferrandina C., Nicoletti I., Mannarelli C., Pippi R., and Santeusanio F. Alpha-adrenergic system in the modulation of pancreatic A and B cell function in normal rats. Diabetes Res. Clin. Pract. 2 (1986) 325-336
16. Gilon P., and Henquin J.C. Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr. Rev. 22 (2001) 565-604
17. Gregorio F., Filipponi P., Cristallini S., Carloni C., Moretti I., Ferrandina C., Pippi R., and Pietropaolo M. Effects of beta non-selective and beta 1 selective adrenergic blocking agents on glucagon secretion from isolated perfused rat pancreas. J. Endocrinol. Invest. 9 (1986) 209-215
18. Guillot E., Coste A., Eon M.T., and Angel I. Mechanisms of the hypoglycemic effects of the alpha2-adrenoceptor antagonists SL84.0418 and deriglidole. Life Sci. 62 (1998) 839-852
19. Hein L., Altman J.D., and Kobilka B.K. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402 (1999) 181-184
20. Hermann L.S., and Deckert T. The effect of epinephrine and isoproterenol on insulin secretion and glucose utilization in isolated islets of Langerhans from mice. Acta Endocrinol. 84 (1977) 105-114
21. Hirose H., Maruyama H., Itoh K., Koyama K., Kido K., and Saruta T. Alpha-2 adrenergic agonism stimulates islet glucagon release from perfused rat pancreas: possible involvement of alpha-2A adrenergic receptor subtype. Acta Endocrinol. 127 (1992) 279-283
22. Hirose H., Maruyama H., Ito K., Koyama K., Kido K., and Saruta T. Glucose-induced insulin secretion and alpha 2-adrenergic receptor subtypes. J. Lab. Clin. Med. 121 (1993) 32-37
23. Hu X., Friedman D., Hill S., Caprioli R., Nicholson W., Powers A.C., Hunter L., and Limbird L.E. Proteomic exploration of pancreatic islets in mice null for the alpha2A adrenergic receptor. J. Mol. Endocrinol. 35 (2005) 73-88
24. Hutson N.J., Brumley F.T., Assimacopoulos F.D., Harper S.C., and Exton J.H. Studies on the alpha-adrenergic activation of hepatic glucose output. I. Studies on the alpha-adrenergic activation of phosphorylase and gluconeogenesis and inactivation of glycogen synthase in isolated rat liver parenchymal cells. . J. Biol. Chem. 251 (1976) 5200-5208
25. James D.E., Burleigh K.M., and Kraegen E.W. In vivo glucose metabolism in individual tissues of the rat. Interaction between epinephrine and insulin. . J. Biol. Chem. 261 (1986) 6366-6374
26. Karlsson S., Scheurink A.J., and Ahrén B. Gender difference in the glucagon response to glucopenic stress in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (2002) R281-R288
27. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., and Quon M.J. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 85 (2000) 2402-2410
28. Kusunoki M., Oshida Y., Iguchi A., Iida T., Suga T., Funado T., Sato Y., Kato K., and Sakamoto N. Influence of sympatho-adrenal system on insulin sensitivity using the euglycemic clamp technique. Diabetes Res. Clin. Pract. 17 (1992) 125-131
29. Langer P. Effects of alpha 1-and alpha 2-adrenoceptors on basal and adrenaline mediated insulin secretion in rats. Endocrinol. Exp. 21 (1987) 285-290
30. Makaritsis K.P., Johns C., Gavras I., Altman J.D., Handy D.E., Bresnahan M.R., and Gavras H. Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype. Hypertension 34 (1999) 403-407
31. Narimiya M., Yamada H., Matsuba I., Ikeda Y., Tanese T., and Abe M. Adrenergic modulation of insulin and glucagon secretion from the isolated perfused rat pancreas. Endocrinol. Jpn. 28 (1981) 281-292
32. Nonogaki K., Iguchi A., and Sakamoto N. Effects of adrenoceptor antagonists on the hyperthermia and hyperglycemia induced by prostaglandin F2 alpha in rats. Eur. J. Pharmacol. 262 (1994) 177-180
33. Oda S., Fujimura H., Sasaki Y., and Ohneda A. Alpha 2-adrenergic modulation of glucagon and insulin secretions in sheep. Tohoku J. Exp. Med. 163 (1991) 101-110
34. Peterhoff M., Sieg A., Brede M., Chao C.M., Hein L., and Ullrich S. Inhibition of insulin secretion via distinct signaling pathways in alpha2-adrenoceptor knockout mice. Eur. J. Endocrinol. 149 (2003) 343-350
35. Schuit F.C., and Pipeleers D.G. Differences in adrenergic recognition by pancreatic A and B cells. Science 232 (1986) 875-877
36. Shimazu T. Glycogen synthetase activity in liver: regulation by the autonomic nerves. Science 156 (1967) 1256-1257
37. Ste Marie L., and Palmiter R.D. Norepinephrine and epinephrine-deficient mice are hyperinsulinemic and have lower blood glucose. Endocrinology 144 (2003) 4427-4432
38. Ste Marie L., Luquet S., Curtis W., and Palmiter R.D. Norepinephrine-and epinephrine-deficient mice gain weight normally on a high-fat diet. Obes. Res. 13 (2005) 1518-1522
39. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., and Feinglos M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988) 1163-1167
40. Van Ermen A., Van de Velde V., Vanscheeuwijck P., and Fraeyman N. Influence of age on the beta 1-and beta 2-adrenergic receptors in rat liver. Mol. Pharmacol. 42 (1992) 649-655
41. Viollet B., Andreelli F., Jørgensen S.B., Perrin C., Flamez D., Mu J., Wojtaszewski J.F., Schuit F.C., Birnbaum M., Richter E., Burcelin R., and Vaulont S. Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem. Soc. Trans. 31 (2003) 216-219